Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cheadle

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2025
Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinomaD Majorova, R Samuel, R Muirhead, et al.
Cancer Research|October 3, 2014
Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockadeSimon J Dovedi, Amy L Adlard, Grazyna Lipowska-Bhalla, et al.
Mucosal Immunology|October 31, 2025
CCR2-driven monocyte recruitment is protective against radiotherapy-induced intestinal toxicityNabina Pun, Urszula M Cytlak, Dave Lee, et al.
Oncoimmunology|June 19, 2023
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1Debayan Mukherjee, Erminia Romano, Richard Walshaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2017
Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 BlockadeSimon J Dovedi, Eleanor J Cheadle, Amy L Popple, et al.
Human Molecular Genetics|September 26, 2000
Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317QH Lamlum, N Al Tassan, E Jaeger, et al.
Oncotarget|March 10, 2016
Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapySimon J Dovedi, Amy L Adlard, Yosuke Ota, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2022
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal CancerJames M Price, Hitesh B Mistry, Guy Betts, et al.
Nature|December 3, 2013
Primitive layered gabbros from fast-spreading lower oceanic crustKathryn M Gillis, Jonathan E Snow, Adam Klaus, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2025
Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinomaD Majorova, R Samuel, R Muirhead, et al.
Cancer Research|October 3, 2014
Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockadeSimon J Dovedi, Amy L Adlard, Grazyna Lipowska-Bhalla, et al.
Mucosal Immunology|October 31, 2025
CCR2-driven monocyte recruitment is protective against radiotherapy-induced intestinal toxicityNabina Pun, Urszula M Cytlak, Dave Lee, et al.
Oncoimmunology|June 19, 2023
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1Debayan Mukherjee, Erminia Romano, Richard Walshaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2017
Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 BlockadeSimon J Dovedi, Eleanor J Cheadle, Amy L Popple, et al.
Human Molecular Genetics|September 26, 2000
Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317QH Lamlum, N Al Tassan, E Jaeger, et al.
Oncotarget|March 10, 2016
Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapySimon J Dovedi, Amy L Adlard, Yosuke Ota, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2022
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal CancerJames M Price, Hitesh B Mistry, Guy Betts, et al.
Nature|December 3, 2013
Primitive layered gabbros from fast-spreading lower oceanic crustKathryn M Gillis, Jonathan E Snow, Adam Klaus, et al.
Pageof 8